Cargando…
Conservation of oncofetal antigens on human embryonic stem cells enables discovery of monoclonal antibodies against cancer
Monoclonal antibodies (mAbs) are used as targeted therapies against cancers. These mAbs kill cancer cells via various mechanisms of actions. In this study, human embryonic stem cells (hESCs) was used as the immunogen to generate a panel of antibodies. From this panel of mAbs, A19 was found to bind b...
Autores principales: | Tan, Heng Liang, Yong, Charlene, Tan, Bao Zhu, Fong, Wey Jia, Padmanabhan, Jayanthi, Chin, Angela, Ding, Vanessa, Lau, Ally, Zheng, Lu, Bi, Xuezhi, Yang, Yuansheng, Choo, Andre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072701/ https://www.ncbi.nlm.nih.gov/pubmed/30072783 http://dx.doi.org/10.1038/s41598-018-30070-z |
Ejemplares similares
-
Targeting of embryonic annexin A2 expressed on ovarian and breast cancer by the novel monoclonal antibody 2448
por: Cua, Simeon, et al.
Publicado: (2018) -
Opportunities for Antibody Discovery Using Human Pluripotent Stem Cells: Conservation of Oncofetal Targets
por: Tan, Heng Liang, et al.
Publicado: (2019) -
Tenascin and oncofetal fibronectin--oncofetal markers or indicators of extracellular matrix remodelling?
por: David, L.
Publicado: (1996) -
CXCR4 Mediated Chemotaxis Is Regulated by 5T4 Oncofetal Glycoprotein in Mouse Embryonic Cells
por: Southgate, Thomas D., et al.
Publicado: (2010) -
In vivo surveillance and elimination of teratoma‐forming human embryonic stem cells with monoclonal antibody 2448 targeting annexin A2
por: Tan, Heng Liang, et al.
Publicado: (2019)